Global Medical Photobiostimulation System Market Forecast to 2028: Focus on Pain Management, Wound Care, Cosmetic Applications - ResearchAndMarkets.com
Pain Management Segment to Hold Largest Share of Medical Photobiostimulation System Market During 2021-2028.
Medical Photobiostimulation System Market is projected to reach US$ 314.88 million by 2028 from US$ 204.66 million in 2021; it is expected to grow at a CAGR of 6.3% from 2021 to 2028.
The medical photobiostimulation system market witnessed some shortfall at the beginning of COVID-19 crisis owing to factors such as disruption in supply chain and demand due to lock down announced by majority of European countries.
Based on application, the medical photobiostimulation system market is segmented into pain management, wound care, cosmetic applications, others. The pain management segment is estimated to hold the largest share of the market in 2021; however wound care segment is estimated to register the highest CAGR in the market during the forecast period.
The growth of the market for wound care segment is attributed to increasing aging population and increasing incidences of infection in diabetic foot ulcers.
Key Market Dynamics
Market Drivers
Growing Number of Patients Suffering from Chronic Disorders and Chronic Pain
Rising Demand for Photobiostimulation Devices for Pain Management and Wound Care Due to Increasing Geriatric Population
Market Restraints
Stringent Regulatory Framework
Market Opportunities
Rising Demand for Minimally Invasive and Noninvasive Therapies
Future Trends
Continuous Technological Advancements in Medical Photobiostimulation Systems
Leading companies operating in the global medical photobiostimulation system market are
BioLight Technologies LLC.
Omega Laser Systems Ltd
Vielight Inc.
Theradome Inc.
Lexington Intl., LLC
THOR Photomedicine Ltd
Ingeneus
iRestore Hair Growth System
Meditech International Inc. (BIOFLEX Laser Therapy)
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announces the formation of a new...
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against QuidelOrtho Corporation ("QuidelOrtho" or "the Company") for violations of 10(b) and 20(a) of the Securities...
TaiGen Biotechnology Company, Limited ("TaiGen") announces today that the business partner, Joincare Pharmaceutical, has completed the unblinding of influenza antiviral TG-1000 phase III study. Preliminary data shows that the median time to...
Mentor Capital, Inc. , a classic energy company, in its 2023 10-K, reported cash of $0.10 per share with no net debt versus today's share price of $0.04 per share. During 2023, the Company announced that the theoretical cash breakup value of the...
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, declared today a cash distribution of Ps. 777.7 million (US$46.5 million), or Ps. 0.5892 per Certificado Bursátil Fiduciario Inmobiliario...
FIBRA Prologis (BMV:FIBRAPL 14), a leading owner and operator of Class-A industrial real estate in Mexico, today reported results for the first quarter 2024.
HIGHLIGHTS FROM THE QUARTER:
Net effective rents on rollover were 47.7 percent.Period-end...